The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Balchem Corp

Nasdaq: BCPC
Last

(U.S.) $57.96

Today's change-0.77 -1.31%
Updated September 3 12:13 PM EDT. Delayed by at least 15 minutes.
 

Balchem Corp

Nasdaq: BCPC
Last

(U.S.) $57.96

Today's change-0.77 -1.31%
Updated September 3 12:13 PM EDT. Delayed by at least 15 minutes.

Balchem Corp crosses below 200-day moving average

Balchem Corp is lower today, dropping (U.S.)$0.77 or 1.31% to (U.S.)$57.96 and crossing below its 200-day moving average. Over the last five days, shares have gained 0.31%, but are down 13.03% for the last year to date. Shares have outperformed the S&P 500 by 10.65% during the last year.

Key company metrics

  • Open(U.S.) $58.52
  • Previous close(U.S.) $58.73
  • High(U.S.) $58.97
  • Low(U.S.) $57.43
  • Bid / Ask(U.S.) $57.74 / (U.S.) $57.96
  • YTD % change-13.03%
  • Volume49,958
  • Average volume (10-day)153,407
  • Average volume (1-month)178,682
  • Average volume (3-month)166,868
  • 52-week range(U.S.) $50.81 to (U.S.) $69.92
  • Beta0.66
  • Trailing P/E28.30×
  • P/E 1 year forward23.54×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $0.30
  • Dividend yield0.52%
  • Trailing EPS(U.S.) $2.05
Updated September 3 12:13 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.67%

Based on its net profit margin of 10.67%, Balchem Corp is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.67%Sector:Basic MaterialsIndustry:Chemicals - Specialty
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue135145163160
Total other revenue--------
Total revenue135145163160
Gross profit42434444
Total cost of revenue93102119116
Total operating expense111120136135
Selling / general / administrative17171617
Research & development1111
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)00--0
Other operating expenses, total--------
Operating income24252725
Interest income (expense), net non-operating-2-2-2-2
Gain (loss) on sale of assets--------
Other--------
Income before tax22232523
Income after tax15151915
Income tax, total7868
Net income15151915
Total adjustments to net income--------
Net income before extra. items15151915
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items15151915
Inc. avail. to common incl. extra. items15151915
Diluted net income15151915
Dilution adjustment--------
Diluted weighted average shares32313131
Diluted EPS excluding extraordinary itemsvalue per share0.470.480.610.49
Dividends per sharevalue per share0.000.000.300.00
Diluted normalized EPSvalue per share0.470.480.540.50